Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2013 Earnings

6NovConfirmed

Q1 1

Q3 2013

Q4 2013

-3.59

-2.62

-1.64

-0.66

Details

Expected EPS

N/A

Actual EPS

-1.095696

Surprise EPS

-1.1

Surprise Percent

+∞%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -1.095696 per share for Q4 2013.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.